Ardelyx Prepares for Battle with FDA Over Rejected CKD
Nov 05 2022 · Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug Ardelyx Inc is lacing up the gloves and preparing to wade into the ring with the Food and Drug Administration FDA to dispute the July rejection of its chronic kidney disease drug tenapanor On Thursday Ardelyx said it will submit a Formal Dispute Resolution Request FDRR